Delivery Order SPE2DB22D1017-SPE2DB24FF4HW
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $2.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The order, valued at $15,285.04, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, SPE2DB22D3004|SPE2DB24FPQ39, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The $3,347.93 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp, as the prime contractor, holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $11,922.74, has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $24,138.15, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a $14,143.79 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FEGB9 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mg/3 ml Ozempic 1 mg/dose medication. The firm fixed price delivery order, valued at $4,090.12, has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,129.08 award is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The delivery order has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $7,118.58 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The delivery order has a completion date of February 6, 2024 and was awarded on February 5, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $4,161.12 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3mL medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract...